Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05141903 · ClinicalTrials.gov registry record

Dietary Supplement With and Without a Probiotic and/or Antibiotic

A clinical trial of Healthy Adults, sponsored by Prolacta Bioscience.

Completed
Registry status
92
Enrollment target
1
Study location

NCT05141903 is a study of Healthy Adults that has completed, run by Prolacta Bioscience. The registered enrollment target is 92 participants, above the 84-participant average among 33 other Healthy Adults trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05141903, a study of Healthy Adults, has completed, sponsored by Prolacta Bioscience.

COMPLETED
Registry status
92 participants
Enrollment target
1
Study location

Study Summary

Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Probiotic
  • DIETARY_SUPPLEMENT Antibiotic
  • DIETARY_SUPPLEMENT HMO Concentrate
  • DIETARY_SUPPLEMENT Food Supplement

Study Locations (1)

California

  • Altasciences - Cypress

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2021-09-21
Est. Completion 2022-06-09

Sponsor

Prolacta Bioscience

7 total trials

What the Registry Record Tells You About NCT05141903

The ClinicalTrials.gov registry entry for NCT05141903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 84-participant average among 33 other Healthy Adults trials with a reported enrollment target (10% higher). The listed sponsor is Prolacta Bioscience, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 4 interventions - of which Probiotic is the first listed.

NCT05141903 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05141903 about?

NCT05141903 is a clinical study titled "Dietary Supplement With and Without a Probiotic and/or Antibiotic". Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.

What is the current status of trial NCT05141903?

This trial is currently completed. The enrollment target is 92 participants. The study started on 2021-09-21. Estimated completion is 2022-06-09.

What conditions does trial NCT05141903 study?

This clinical trial studies the following conditions: Healthy Adults.

What interventions are being tested in trial NCT05141903?

The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT), Antibiotic (DIETARY_SUPPLEMENT), HMO Concentrate (DIETARY_SUPPLEMENT), Food Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05141903?

This trial is sponsored by Prolacta Bioscience, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05141903 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.